1. A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms. Issue 2 (27th November 2017) Authors: Assi, Rita; Kantarjian, Hagop M.; Garcia‐Manero, Guillermo; Cortes, Jorge E.; Pemmaraju, Naveen; Wang, Xuemei; Nogueras‐Gonzalez, Graciela; Jabbour, Elias; Bose, Prithviraj; Kadia, Tapan; Dinardo, Courtney D.; Patel, Keyur; Bueso‐Ramos, Carlos; Zhou, Lingsha; Pierce, Sherry; Gergis, Romany; Tuttl... Journal: American journal of hematology Issue: Volume 93:Issue 2(2018:Feb.) Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cladribine and low-dose cytarabine alternating with decitabine as front-line therapy for elderly patients with acute myeloid leukaemia: a phase 2 single-arm trial. Issue 9 (September 2018) Authors: Kadia, Tapan M; Cortes, Jorge; Ravandi, Farhad; Jabbour, Elias; Konopleva, Marina; Benton, Christopher B; Burger, Jan; Sasaki, Koji; Borthakur, Gautam; DiNardo, Courtney D; Pemmaraju, Naveen; Daver, Naval; Ferrajoli, Alessandra; Wang, Xuemei; Patel, Keyur; Jorgensen, Jeffrey L; Wang, Sa; O'Brien,... Journal: Lancet Issue: Volume 5:Issue 9(2018) Page Start: e411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗